Business Context and Reporting Period
Company: enVVeno Medical Corporation (NVNO)
Filing Type: Form 8-K (Current Report)
Date of Report: February 4, 2026
Reporting Period: As of December 31, 2025
Key Financial Metrics
- Cash and Investments: Approximately $28 million as of December 31, 2025.
- Revenue, Profit, Margins, Debt: The filing text does not provide clear values for these metrics.
Material Changes and Events
- NASDAQ Compliance: The Company announced it regained compliance with the minimum bid price requirement and all other criteria for continued listing on The NASDAQ Stock Market.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future operations, or detailed risk factors beyond the context of regaining listing compliance.
Investor Verification Checklist
- Verify the exact cash and investment balance of $28 million in the Company's most recent audited financial statements.
- Confirm the specific minimum bid price threshold met to regain NASDAQ compliance.
- Review the attached Press Release (Exhibit 99.1) for additional details on the compliance restoration.